CDT Logo

Conduit Pharmaceuticals Inc. (CDT) 

NASDAQ
Market Cap
$7.08M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
Rank in Industry

Largest Insider Buys in Sector

CDT Stock Price History Chart

CDT Stock Performance

About Conduit Pharmaceuticals Inc.

Conduit Pharmaceuticals Inc. operates as a clinical stage specialty biopharmaceutical company that provides unmet medical needs in the areas of autoimmune disease and idiopathic male infertility. It's pipeline includes AZD1656 for the treatment of hashimoto's thyroiditis, renal transplant, uveitis, and preterm labor; and AZD5904 for the treatment of idiopathic male infertility. The company was founded in 2019 and is based in San Diego, California. Conduit Pharmaceuticals Limited is a subsidiary of Corvus Capital Limited.

Insider Activity of Conduit Pharmaceuticals Inc.

Over the last 12 months, insiders at Conduit Pharmaceuticals Inc. have bought $0 and sold $0 worth of Conduit Pharmaceuticals Inc. stock.

On average, over the past 5 years, insiders at Conduit Pharmaceuticals Inc. have bought $0 and sold $5.28M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

List of Insider Buy and Sell Transactions, Conduit Pharmaceuticals Inc.

2024-10-07Sale10 percent owner
939,009
0.7806%
$0.10$96,530+3.35%
2024-10-04Sale10 percent owner
1.37M
1.1359%
$0.10$140,458+3.74%
2024-10-03Sale10 percent owner
1.5M
1.2652%
$0.10$156,450+4.11%
2024-10-02Sale10 percent owner
333,177
0.277%
$0.10$34,251+7.79%
2024-10-01Sale10 percent owner
1.25M
1.1433%
$0.11$141,375-3.82%
2024-09-30Sale10 percent owner
1.02M
0.9868%
$0.12$122,019-13.59%
2024-07-17Sale
1.51M
3.272%
$0.26$391,092-53.53%
2024-07-16Sale
10.24M
27.1611%
$0.32$3.25M-50.14%
2024-07-15Sale
1.01M
2.0781%
$0.25$248,385-47.75%
2024-07-12Sale
1.39M
2.8732%
$0.25$343,425-52.11%
2024-07-11Sale
882,952
2.1777%
$0.29$260,253-56.55%
2024-07-10Sale
150,000
0.4189%
$0.33$50,070-57.24%
2024-07-09Sale
77,681
0.2832%
$0.44$33,853-69.78%
2024-07-08Sale
35,923
0.1533%
$0.51$18,321-74.68%
2024-07-03Sale
1,000
0.0054%
$0.64$640-80.03%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.